New Advance in Primary and Secondary Immunodeficiencies
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Hematology and Immunology".
Deadline for manuscript submissions: 22 June 2026 | Viewed by 36
Special Issue Editors
Interests: inborn errors of immunity; immunogenetics; primary and secondary immunodeficiency; food allergy
Special Issue Information
Dear Colleagues,
For this Special Issue of Medicina entitled “New Advance in Primary and Secondary Immunodeficiencies,” we will be exploring cutting-edge research and practice changes in the field of inborn errors of immunity and immune dysregulation. This Issue is focused on providing a practical clinical framework for immunologists and other specialties within medicine and research. The field of immunodeficiency is rapidly changing with new therapies and diagnostics now available in addition to the emergence of expanding diseases being discovered. With the increasing availability and awareness of immunogenetics, targeted therapies are now possible for many inborn errors of immunity. Biologics with specific targets for immune dysregulation are enabling a more targeted approach to immune control for a quiescent disease. Furthermore, secondary immunodeficiency, particularly with regard to solid organ and hematopoietic transplantation, malignancy, and immunosuppression, is now being managed more often by the immunologist with personalized therapeutics. This issue will explore these new challenges and advantages in the field of medicine with regard to immunodeficiency.
Dr. Gary Ira Kleiner
Guest Editor
Dr. Melissa Gans
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inborn errors of immunity
- immunogenetics
- primary immunodeficiency
- secondary immunodeficiency
- immunomodulators
- stem cell transplant
- gene therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
